title: Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets.
abstract: The onset of heart failure is typically preceded by cardiac hypertrophy, a response of the heart to increased workload, a cardiac insult such as a heart attack or genetic mutation. Cardiac hypertrophy is usually characterized by an increase in cardiomyocyte size and thickening of ventricular walls. Initially, such growth is an adaptive response to maintain cardiac function; however, in settings of sustained stress and as time progresses, these changes become maladaptive and the heart ultimately fails. In this review, we discuss the key features of pathological cardiac hypertrophy and the numerous mediators that have been found to be involved in the pathogenesis of cardiac hypertrophy affecting gene transcription, calcium handling, protein synthesis, metabolism, autophagy, oxidative stress and inflammation. We also discuss new mediators including signaling proteins, microRNAs, long noncoding RNAs and new findings related to the role of calcineurin and calcium-/calmodulin-dependent protein kinases. We also highlight mediators and processes which contribute to the transition from adaptive cardiac remodeling to maladaptive remodeling and heart failure. Treatment strategies for heart failure commonly include diuretics, angiotensin converting enzyme inhibitors, angiotensin II receptor blockers and β-blockers; however, mortality rates remain high. Here, we discuss new therapeutic approaches (e.g., RNA-based therapies, dietary supplementation, small molecules) either entering clinical trials or in preclinical development. Finally, we address the challenges that remain in translating these discoveries to new and approved therapies for heart failure.
authors.affiliation: Baker IDI Heart and Diabetes Institute, PO Box 6492, Melbourne, 3004, Australia.
authors.forename: Yow Keat
authors.initials: YK
authors.lastname: Tham
authors.forename: Bianca C
authors.initials: BC
authors.lastname: Bernardo
authors.forename: Jenny Y Y
authors.initials: JY
authors.lastname: Ooi
authors.forename: Kate L
authors.initials: KL
authors.lastname: Weeks
authors.forename: Julie R
authors.initials: JR
authors.lastname: McMullen
mesh_terms: D000818:Animals; D006332:Cardiomegaly / Q000503:physiopathology* / Q000628:therapy; D006333:Heart Failure / Q000503:physiopathology* / Q000628:therapy; D006352:Heart Ventricles / Q000473:pathology; D006801:Humans; D032383:Myocytes, Cardiac / Q000473:pathology*; D015398:Signal Transduction / Q000502:physiology